Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Formal Take-over Bid to Commence on January 23, 2019; Receives Commitment for C$150 Million Equity Investment Cannabis Investing News
Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy Life Science Investing News
Concert Pharmaceuticals Completes Enrollment of 12 mg Cohort in Phase 2a Trial Life Science Investing News
Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis Life Science Investing News
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 Life Science Investing News
MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 Pharmaceutical Investing
